Press Announcements > FDA permits marketing of device to treat diabetic foot ulcers
FDA permits marketing of device to treat diabetic foot ulcers
Today, the U.S. Food and Drug Administration permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers. Continue reading.
Headache Disorders in Pandemic Conditions
Hace 14 horas
No hay comentarios:
Publicar un comentario